Replimune (REPL) Treasury Shares (2018 - 2025)
Replimune's (REPL) quarterly Treasury Shares came in at $5.7 million in Q4 2025, up 62.2% year-on-year from $3.5 million in Q4 2024, and up 10.88% quarter-over-quarter from $5.1 million in Q3 2025.
Replimune (REPL) Treasury Shares (2018 - 2025) Analysis & Trends
Replimune has disclosed Treasury Shares across 7 years of filings, most recently posting $5.7 million for Q4 2025.
- Treasury Shares for Q4 2025 came in at $5.7 million, up 62.2% year-over-year; the trailing twelve-month figure through Dec 2025 was $5.7 million (up 62.2% YoY), and the FY2025 annual result was $3.6 million, up 50.62% from the prior year.
- Treasury Shares came in at $5.7 million for Q4 2025 at Replimune, up from $5.1 million in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $5.7 million in Q4 2025 to a low of $15975.0 in Q1 2021.
- The 5-year median for Treasury Shares is $2.1 million (2023), against an average of $2.3 million.
- Across the five-year window, Treasury Shares surged 5071.91% in 2022 and jumped 46.07% in 2025, its largest moves.
- Replimune's Treasury Shares stood at $782004.0 in 2021, then jumped by 73.11% to $1.4 million in 2022, then soared by 50.77% to $2.0 million in 2023, then jumped by 71.06% to $3.5 million in 2024, then soared by 62.2% to $5.7 million in 2025.
- The last three Treasury Shares figures came in at $5.7 million (Q4 2025), $5.1 million (Q3 2025), and $5.2 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Replimune | 780.01 Mn | 510.88 Mn | - | 5.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.66 Mn |
| Dec 31, 2025 | 5.66 Mn |
| Sep 30, 2025 | 5.11 Mn |
| Sep 30, 2025 | 5.11 Mn |
| Jun 30, 2025 | 5.23 Mn |
| Jun 30, 2025 | 5.23 Mn |
| Mar 31, 2025 | 3.61 Mn |
| Mar 31, 2025 | 3.61 Mn |
| Dec 31, 2024 | 3.49 Mn |
| Dec 31, 2024 | 3.49 Mn |
| Sep 30, 2024 | 3.50 Mn |
| Sep 30, 2024 | 3.50 Mn |
| Jun 30, 2024 | 3.37 Mn |
| Jun 30, 2024 | 3.37 Mn |
| Mar 31, 2024 | 2.40 Mn |
| Mar 31, 2024 | 2.40 Mn |
| Dec 31, 2023 | 2.04 Mn |
| Dec 31, 2023 | 2.04 Mn |
| Sep 30, 2023 | 2.19 Mn |
| Sep 30, 2023 | 2.19 Mn |